# DoW Neurofibromatosis Investigator-Initiated Research Award

Source: https://welltoldgrants.com/grants/ht942526nfrpiira-dow-neurofibromatosis-investigator-initiated-research-award/  
Official notice: https://www.grants.gov/search-results-detail/362975

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 7 awards worth $6.0 million in total. Applications closed on September 22, 2026.

| Field | Value |
|---|---|
| Opportunity number | HT942526NFRPIIRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 22, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 7 |
| Total funding | $6.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project. Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features: • Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community. • Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists. The funding levels are defined as follows: • Level 1: Applications without an optional feature. • Level 2: Applications including one of the optional features.

## Questions people ask

### Is HT942526NFRPIIRA still open?

No. It closed on September 22, 2026. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoW Neurofibromatosis Investigator-Initiated Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoW Neurofibromatosis Investigator-Initiated Research Award?

Closed September 22, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $6.0 million in total across about 7 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.